129 related articles for article (PubMed ID: 24441506)
21. Sox10-iCreERT2 : a mouse line to inducibly trace the neural crest and oligodendrocyte lineage.
Simon C; Lickert H; Götz M; Dimou L
Genesis; 2012 Jun; 50(6):506-15. PubMed ID: 22173870
[TBL] [Abstract][Full Text] [Related]
22. Melanoma genetics: the other side.
Bis S; Tsao H
Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
[TBL] [Abstract][Full Text] [Related]
23. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
24. Targeted therapy for melanoma: rational combinatorial approaches.
Kwong LN; Davies MA
Oncogene; 2014 Jan; 33(1):1-9. PubMed ID: 23416974
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
26. The adult hair follicle: cradle for pluripotent neural crest stem cells.
Sieber-Blum M; Grim M
Birth Defects Res C Embryo Today; 2004 Jun; 72(2):162-72. PubMed ID: 15269890
[TBL] [Abstract][Full Text] [Related]
27. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
[TBL] [Abstract][Full Text] [Related]
28. New therapeutical strategies in the treatment of metastatic disease.
Julia F; Thomas L; Dalle S
Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
Li W; Melton DW
Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
[TBL] [Abstract][Full Text] [Related]
30. Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation.
McKeown SJ; Lee VM; Bronner-Fraser M; Newgreen DF; Farlie PG
Dev Dyn; 2005 Jun; 233(2):430-44. PubMed ID: 15768395
[TBL] [Abstract][Full Text] [Related]
31. RAC1 as a Therapeutic Target in Malignant Melanoma.
Cannon AC; Uribe-Alvarez C; Chernoff J
Trends Cancer; 2020 Jun; 6(6):478-488. PubMed ID: 32460002
[TBL] [Abstract][Full Text] [Related]
32. LSox5 regulates RhoB expression in the neural tube and promotes generation of the neural crest.
Perez-Alcala S; Nieto MA; Barbas JA
Development; 2004 Sep; 131(18):4455-65. PubMed ID: 15306568
[TBL] [Abstract][Full Text] [Related]
33. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth.
Ghislin S; Deshayes F; Lauriol J; Middendorp S; Martins I; Al-Daccak R; Alcaide-Loridan C
Melanoma Res; 2012 Jun; 22(3):184-94. PubMed ID: 22454190
[TBL] [Abstract][Full Text] [Related]
34. Signaling pathways bridging fate determination of neural crest cells to glial lineages in the developing peripheral nervous system.
Kipanyula MJ; Kimaro WH; Yepnjio FN; Aldebasi YH; Farahna M; Nwabo Kamdje AH; Abdel-Magied EM; Seke Etet PF
Cell Signal; 2014 Apr; 26(4):673-82. PubMed ID: 24378534
[TBL] [Abstract][Full Text] [Related]
35. RAC1 and melanoma.
Halaban R
Clin Ther; 2015 Mar; 37(3):682-5. PubMed ID: 25465943
[TBL] [Abstract][Full Text] [Related]
36. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
Park S; Yeung ML; Beach S; Shields JM; Yeung KC
Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
[TBL] [Abstract][Full Text] [Related]
37. New therapeutic options in the medical management of advanced melanoma.
Lutzky J
Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
[TBL] [Abstract][Full Text] [Related]
38. Developmental chromatin programs determine oncogenic competence in melanoma.
Baggiolini A; Callahan SJ; Montal E; Weiss JM; Trieu T; Tagore MM; Tischfield SE; Walsh RM; Suresh S; Fan Y; Campbell NR; Perlee SC; Saurat N; Hunter MV; Simon-Vermot T; Huang TH; Ma Y; Hollmann T; Tickoo SK; Taylor BS; Khurana E; Koche RP; Studer L; White RM
Science; 2021 Sep; 373(6559):eabc1048. PubMed ID: 34516843
[TBL] [Abstract][Full Text] [Related]
39. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.
Shakhova O; Zingg D; Schaefer SM; Hari L; Civenni G; Blunschi J; Claudinot S; Okoniewski M; Beermann F; Mihic-Probst D; Moch H; Wegner M; Dummer R; Barrandon Y; Cinelli P; Sommer L
Nat Cell Biol; 2012 Aug; 14(8):882-90. PubMed ID: 22772081
[TBL] [Abstract][Full Text] [Related]
40. Enhanced SOX10 and KIT expression in cutaneous melanoma.
Rönnstrand L; Phung B
Med Oncol; 2013; 30(3):648. PubMed ID: 23801280
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
